The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice.

MLA

Hao, Huifeng, et al. “The Cyclic Adenosine Monophosphate Elevating Medicine, Forskolin, Reduces Neointimal Formation and Atherogenesis in Mice.” Journal of Cellular and Molecular Medicine, vol. 24, no. 17, Sept. 2020, pp. 9638–45. EBSCOhost, https://doi.org/10.1111/jcmm.15476.

APA

Hao, H., Ma, X., Chen, H., Zhu, L., Xu, Z., Li, Q., Xu, C., Zhang, Y., Peng, Z., & Wang, M. (2020). The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice. Journal of Cellular and Molecular Medicine, 24(17), 9638–9645. https://doi.org/10.1111/jcmm.15476

Chicago

Hao, Huifeng, Xiaoyan Ma, Hong Chen, Liyuan Zhu, Zhenyu Xu, Qiaoling Li, Chuansheng Xu, Yuze Zhang, Zekun Peng, and Miao Wang. 2020. “The Cyclic Adenosine Monophosphate Elevating Medicine, Forskolin, Reduces Neointimal Formation and Atherogenesis in Mice.” Journal of Cellular and Molecular Medicine 24 (17): 9638–45. doi:10.1111/jcmm.15476.